Reduction of Werner Syndrome Protein Enhances G:C → A:T Transition by O6-Methylguanine in Human Cells.
Tetsuya SuzukiYoshie KuramotoHiroyuki KamiyaPublished in: Chemical research in toxicology (2018)
O6-Methylguanine ( O6-MeG) is a damaged base produced by methylating reagents. The Werner syndrome protein (WRN) is a cancer-related human DNA helicase. The effects of WRN reduction on O6-MeG-caused mutagenesis were assessed by an siRNA-mediated knockdown in human U2OS cells, using a shuttle plasmid with a single O6-MeG base in the supF gene. The plasmid DNA was replicated in the cells, isolated, and electroporated into an Escherichia coli indicator strain. The lowered amount of WRN increased the frequency of mutations induced by O6-MeG, mainly G:C → A:T substitution. The increased mutation rate suggested that the cancer-related WRN suppresses the G:C → A:T substitution by O6-MeG in human cells.
Keyphrases
- escherichia coli
- induced apoptosis
- endothelial cells
- resting state
- crispr cas
- cell cycle arrest
- single molecule
- signaling pathway
- induced pluripotent stem cells
- functional connectivity
- cell free
- oxidative stress
- pluripotent stem cells
- case report
- endoplasmic reticulum stress
- genome wide
- pseudomonas aeruginosa
- small molecule
- cystic fibrosis
- transcription factor
- pi k akt
- genome wide identification